WAVEMAN · COMPANY

RPM · Rpm International Inc/De/

LIVE

TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475

← ALL COMPANIES

RPM

Name: RPM INTERNATIONAL INC/DE/ (RPM) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

RPM INTERNATIONAL INC/DE/

PHARMA & BIOTECH · PAINTS, VARNISHES, LACQUERS, ENAMELS & ALLIED PRODS · CIK 0000110621

CONGRESS · 1☆ WATCH

INSIDER NET · 180D

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

13F, latest reported quarter

REVENUE GROWTH

+6.7%

XBRL, annual

NET MARGIN

8.4%

CONVERSIONS · 180D

codes C/M, not in net · $15.5M priced

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

no Form 4 purchases or sales on file

CONGRESS

1 member bought in the last year

the lowest in Pharma & Biotech

FUNDS

fewer than five institutions report holding it

REVENUE

+6.7% year over year

more than 57% of Pharma & Biotech

MARGIN

8.4% net margin

more than 78% of Pharma & Biotech

BUYBACKS

$77.5M repurchased, FY to 2026-05-31

more than 64% of Pharma & Biotech

SHORT

no short interest reported

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

1 member of Congress reported buying it this year.

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN -14.3%

-14.3%12M

INSIDER SELL

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

The complete filing record, in one place.

The record shows 1 Congress member(s) bought in 12 months. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

UTHR CPIX MRNA REGN LLY ALNY ELF CITR MDGL DNA VRTX NUVL

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

No insider purchases or sales are on record for RPM INTERNATIONAL INC/DE/ in the period covered. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER

FILED

VALUE

Kinser Timothy R.

VP-Operations

SELL

2026-01-21

3,441.0

$379.6K

Nance Frederick R.

Director

SELL

2025-11-11

792.0

$85.5K

FAZZOLARI SALVATORE D

Director

SELL

2025-10-31

375.0

$40.4K

Nance Frederick R.

Director

SELL

2025-08-06

1,000.0

$119.4K

Nance Frederick R.

Director

SELL

2024-11-14

594.0

$80.5K

32 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 27 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

no 13F holders found for this ticker

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

FORM 144

No planned-sale notices

No insider has notified an intent to sell. This is the panel to watch after a run-up.

Executive pay vs shareholder return · Mr. Sullivan

DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself

CEO TOTAL

ACTUALLY PAID

OTHER NEOs AVG

TSR

PEER TSR

2025

$11.1M

$7.3M

$3.3M

+24%

-9%

2024

$11.2M

$9.9M

$2.2M

+31%

+1%

2023

$11.7M

$17.7M

$2.7M

+27%

+3%

2022

$6.4M

$2.5M

$1.9M

-11%

-17%

2021

$9.1M

$7.3M

$1.8M

-4%

-10%

TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2026-05	2025-05	2024-05	2023-05
REVENUE	$7.9B	$7.4B	$7.3B	$7.3B
GROSS PROFIT	$3.3B	$3.1B	$3.0B	$2.7B
NET INCOME	$662.0M	$690.0M	$589.0M	$480.0M
EPS (DILUTED)	5.17	5.35	4.56	3.72
OPERATING CASH FLOW	$898.7M	$768.2M	$1.1B	$577.1M
CASH	$315.2M	$302.1M	$237.4M	$215.8M
BUYBACKS	$77.5M	$70.0M	$55.0M	$50.0M
DIVIDENDS PAID	$271.7M	$255.6M	$231.9M	$213.9M

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE